-

MedMen Announces Delay Filing of Financial Statements for the First Fiscal Quarter of 2021, Ended September 26, 2020 and Issuance of Management Cease Trade Order

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the United States, today announced it expects to be late in filing its financial statements and management’s discussion and analysis for the first quarter ended September 26, 2020 (the “Interim Financial Filings”) under applicable Canadian securities laws. The Company has filed a registration statement with the United States Securities and Exchange Commission (the "SEC") in connection with its loss of foreign private issuer status. While the registration statement was declared effective on October 23, 2020, the SEC and the Company are still in the comment phase. Changes to the Company's MD&A have been requested and the Company is still addressing these changes with the assistance of its auditors and legal counsel. The Company anticipates having management’s discussion and analysis for the first quarter of 2021 that fully addresses these comments within the next 10 days such that the Interim Financial Filings will be available for filing by or before December 7, 2020.

MedMen applied for a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”), which was issued today by the British Columbia Securities Commission. The MCTO does not affect the ability of investors who are not insiders to trade in the securities of the Company. MedMen intends to follow the alternate information guidelines contained in National Policy 12-203 for so long as it has not filed the Interim Financial Filings.

ABOUT MEDMEN:

MedMen is a cannabis retailer with flagship locations in California, Nevada, Illinois, Florida, and New York. MedMen offers a robust selection of high-quality products, including MedMen-owned brands [statemade], LuxLyte, and MedMen Red through its premium retail stores, proprietary delivery service, as well as curbside and in-store pick up. MedMen Buds, the Company’s loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier and happier. Learn more about MedMen and The MedMen Foundation at www.medmen.com.

SOURCE: MedMen Enterprises

Contacts

MEDIA CONTACTS:
Julian Labagh
Email: communications@medmen.com

INVESTOR RELATIONS CONTACT:
Zeeshan Hyder
Email: investors@medmen.com

MedMen Enterprises

CNSX:MMEN

Release Versions

Contacts

MEDIA CONTACTS:
Julian Labagh
Email: communications@medmen.com

INVESTOR RELATIONS CONTACT:
Zeeshan Hyder
Email: investors@medmen.com

More News From MedMen Enterprises

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom